Brazil's Goias Poised to Be Major Pharmaceutical Hub

---

Researched by Industrial Info Resources (Sugar Land, Texas)--Brazil's state of Goias is seeing significant growth in its Pharmaceutical & Biotech Industry. Industrial Info is tracking 66 active projects in Goias, with a total investment value of more than $650 million--which is expected to continue its growth in the coming years.

Goias benefits from business incentives and an advantageous location in central-western Brazil. Its city of Anapolis has seen the most industrial development, according to the Instituto Mauro Borges, while the Agribusiness District of Anapolis (DAIA) houses the second-largest pharmaceutical hub in Brazil.

Subscribers to Industrial Info's Pharmaceutical & Biotech Project Database can click here for a list of active projects in Brazil's Pharmaceutical & Biotech Industry.

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn.